Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lipid bilayer headgroup region is the hydrophilic interface of the cellular membrane, composed of the polar portions of phospholipids, sphingolipids, and cholesterol (Alberts et al., Molecular Biology of the Cell). This region serves as the primary interface for interactions between the cell and its environment, facilitating the recruitment of signaling proteins and maintaining the structural integrity of the lipid bilayer (Vance & Vance, Biochemistry of Lipids, Lipoproteins and Membranes). In pharmacology, this region is a critical target for membrane-active drugs, particularly antibiotics like polymyxins and daptomycin, which bind to specific headgroups to disrupt membrane stability or form pores (Velkov et al., 2013, J Med Chem). For instance, daptomycin requires calcium to bind specifically to phosphatidylglycerol headgroups in bacterial membranes (Muller et al., 2016, BBA). Targeting the headgroup region is also a strategy in membrane lipid therapy, where drugs aim to alter membrane composition or physical properties to treat diseases like cancer or metabolic disorders (Escribá et al., 2015, J Cell Mol Med). This approach can modulate the activity of membrane-bound proteins by changing the lateral pressure or curvature of the bilayer. However, the lack of high specificity between microbial and host cell membranes often leads to significant safety concerns, such as nephrotoxicity or hemolysis (Falagas & Kasiakou, 2005, Crit Care).
Binding to polar headgroups to induce membrane permeabilization, pore formation, or disruption of lipid packing (Velkov et al., 2013).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid bilayer headgroup region.